石药集团:SYH2046片获美国临床试验批准

美港电讯
09 May

【石药集团:SYH2046片获美国临床试验批准】金十数据5月9日讯,石药集团公告,集团开发的化药1类新药SYH2046片已获得美国食品药品监督管理局(FDA)批准,可以在美国开展临床试验。该产品亦已于2025年4月获得中华人民共和国国家药品监督管理局批准,可以在中国开展临床试验。SYH2046片是一款具有完全自主知识产权的全新结构first-in-class小分子药物,本次获批的临床试验适应症为急性心肌梗死后心力衰竭。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10